Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06440538 · ClinicalTrials.gov registry record · Early Phase 1

Rebuilding Inter-limb Transfer in Cervical SCI

A Early Phase 1 study of Cervical Spinal Cord Injury, sponsored by The Cleveland Clinic.

Recruiting
Registry status
Early Phase 1
Development phase
17
Enrollment target
1
Study location

NCT06440538 is a Early Phase 1 study of Cervical Spinal Cord Injury that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 17 participants, below the 21-participant average among 18 other Cervical Spinal Cord Injury trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06440538, a Early Phase 1 study of Cervical Spinal Cord Injury, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
Early Phase 1
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study in people living with cervical Spinal Cord Injury (SCI) is to examine the effects of paired neurostimulation (i.e., PCMS) combined with contralateral motor training on inter-limb transfer of ballistic motor and hand dexterity skills.

Interventions

  • DEVICE PCMS + Contralateral Motor Training
  • DEVICE PCMS + Rest
  • DEVICE Sham PCMS + Contralateral Motor Training

Study Locations (1)

Ohio

  • Lerner Research Institute; Cleveland Clinid Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2024-02-15
Est. Completion 2026-07-30
Phase Early Phase 1

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT06440538

The ClinicalTrials.gov registry entry for NCT06440538 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 21-participant average among 18 other Cervical Spinal Cord Injury trials with a reported enrollment target (19% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which PCMS + Contralateral Motor Training is the first listed.

NCT06440538 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06440538 about?

NCT06440538 is a clinical study titled "Rebuilding Inter-limb Transfer in Cervical SCI". The purpose of this study in people living with cervical Spinal Cord Injury (SCI) is to examine the effects of paired neurostimulation (i.e., PCMS) combined with contralateral motor training on inter-limb transfer of ballistic motor and hand dexterity skills.

What is the current status of trial NCT06440538?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 17 participants. The study started on 2024-02-15. Estimated completion is 2026-07-30.

What conditions does trial NCT06440538 study?

This clinical trial studies the following conditions: Cervical Spinal Cord Injury.

What interventions are being tested in trial NCT06440538?

The interventions under investigation include: PCMS + Contralateral Motor Training (DEVICE), PCMS + Rest (DEVICE), Sham PCMS + Contralateral Motor Training (DEVICE).

Who is sponsoring clinical trial NCT06440538?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06440538 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.